ストックスクリーナーアプリを入手
2.52
7.69%
-0.21
アフターアワーズ：
2.54
0.02
+0.79%
Iovance Biotherapeutics Inc (IOVA) 最新ニュース
Iovance Biotherapeutics Inc. (IOVA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Iovance Biotherapeutics (NASDAQ:IOVA) Trading Down 7.1%Here's What Happened - MarketBeat
Why Iovance Biotherapeutics Stock Got Mashed on Monday - MSN
Barclays Adjusts Valuation Targets for Iovance Biotherapeutics (IOVA) Amid Biotech Sector Review - Insider Monkey
2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street - Finviz
Will Iovance Biotherapeutics Inc. stock attract more institutional investorsCovered Call Writing & Budget Friendly Investment Plans - bollywoodhelpline.com
Iovance Biotherapeutics: Bright Prospects For 2026 (NASDAQ:IOVA) - Seeking Alpha
The next front against cancer: A Mugglehead roundup - Mugglehead Magazine
Is Iovance (IOVA) Turning Talent Incentives and TIL Optimism Into a Durable Competitive Edge? - Sahm
Iovance Biotherapeutics (IOVA) Stock News Today: Barclays Raises Target, Short-Interest Pressure, and 2026 Catalysts (Dec. 23, 2025) - ts2.tech
Iovance Biotherapeutics: Is it Time to Invest? - StocksToTrade
Iovance Biotherapeutics (NASDAQ:IOVA) Trading Up 8.7%Still a Buy? - MarketBeat
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(4) - marketscreener.com
Will Iovance Biotherapeutics Inc. stock outperform Nasdaq indexTrade Analysis Summary & Community Verified Trade Signals - ulpravda.ru
Iovance Biotherapeutics, Inc. $IOVA Position Increased by Squarepoint Ops LLC - MarketBeat
Aug Drivers: Why retail investors favor Iovance Biotherapeutics Inc. stockEntry Point & Fast Gain Stock Trading Tips - ulpravda.ru
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
Why Iovance Biotherapeutics Inc. stock attracts high net worth investors - DonanımHaber
How Iovance Biotherapeutics Inc. (2LB) stock valuation compares with sectorGap Down & Weekly High Return Stock Opportunities - DonanımHaber
Iovance Biotherapeutics (IOVA): Assessing Valuation After FDA Progress, Melanoma Data and Upgraded Analyst Targets - Sahm
Insider Buy: Why retail investors favor Iovance Biotherapeutics Inc. stockJobs Report & Weekly Watchlist of Top Performers - Улправда
Market Trends: Is Iovance Biotherapeutics Inc. (2LB) stock cheap vs fundamentalsMarket Activity Report & Weekly High Return Forecasts - Улправда
There Is A Reason Iovance Biotherapeutics, Inc.'s (NASDAQ:IOVA) Price Is Undemanding - 富途牛牛
Iovance Biotherapeutics (IOVA) Stock News Today (Dec. 18, 2025): Barclays Lifts Target to $10, Analysts Stay Split on Amtagvi’s Launch - ts2.tech
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Barclays Maintains Iovance Biotherapeutics (IOVA) Overweight Recommendation - Nasdaq
Barclays Doubles Iovance Biotherapeutics’ Price Target in Bold Market Move - StocksToTrade
Iovance Biotherapeutics (IOVA) Sees Raised Price Target by Barcl - GuruFocus
Iovance Biotherapeutics Advances Innovative Melanoma Treatment with Updated Study - TipRanks
Barclays’ Bullish Outlook Sparks Iovance Stock Surge - timothysykes.com
Mirador Capital Partners LP Makes New Investment in Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
Iovance Biotherapeutics (NASDAQ:IOVA) Shares Up 6.7%Should You Buy? - MarketBeat
Iovance Biotherapeutics (NASDAQ:IOVA) Shares Cross Above Fifty Day Moving AverageHere's Why - MarketBeat
What analysts say about Iovance Biotherapeutics Inc 2LB stockLong-Term Investment Plans & Advanced Stock Screening Tools - earlytimes.in
Securities Lawsuit Alert: Iovance Biotherapeutics, Inc. (IOVA)Contact Levi & Korsinsky Before July 14, 2025 - ACCESS Newswire
Iovance Biotherapeutics Stock: Analyzing Its Surprising Surge - StocksToTrade
Will Iovance Biotherapeutics’ Stock Surge? - timothysykes.com
Iovance Biotherapeutics: A Surge or A Signal to Watch? - timothysykes.com
Iovance Biotherapeutics (IOVA): Is the Market Overlooking a Potential Rebound in Valuation After a Tough Year? - Yahoo Finance
Weighing Iovance Biotherapeutics After a 71.8% Slide and DCF Upside in 2025 - Yahoo Finance
Voss Capital LP Acquires New Shares in Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
With Iovance Biotherapeutics Stock Sliding, Have You Assessed The Risk? - Trefis
2 Stocks That Could Soar by 52% and 282%, According to Wall Street - Finviz
2 Stocks That Could Soar by 52% and 282%, According to Wall Street - The Motley Fool
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), MBX Biosciences, Inc. (MBX) and Praxis Precision Medicines (PRAX) - The Globe and Mail
What earnings margins imply for Iovance Biotherapeutics Inc. (2LB) stockWeekly Stock Analysis & Fast Momentum Stock Entry Tips - Newser
Why Iovance Biotherapeutics Inc. (2LB) stock benefits from AI revolutionJuly 2025 PostEarnings & Safe Capital Investment Plans - Newser
0.57%
大文字化:
|
ボリューム (24 時間):